We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+24.38%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.87B
AUM Growth
+$571M
Cap. Flow
-$98.3M
Cap. Flow %
-2.54%
Top 10 Hldgs %
18.79%
Holding
1,345
New
153
Increased
459
Reduced
571
Closed
93

Sector Composition

Rank Sector Weight
1 Technology 18.06%
2 Healthcare 12.66%
3 Financials 10.15%
4 Consumer Discretionary 9.43%
5 Communication Services 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWKS icon
476
Skyworks Solutions
SWKS
$10.4B
$1.32M 0.03%
10,356
-522
-5% -$57.8K
BWA icon
477
BorgWarner
BWA
$14.1B
$1.32M 0.03%
42,485
+6,591
+18% +$174K
CNBKA
478
DELISTED
Century Bancorp Inc/Mass
CNBKA
$1.32M 0.03%
16,975
+1,450
+9% +$101K
MET icon
479
MetLife
MET
$61.7B
$1.32M 0.03%
36,098
-35,966
-50% -$1.25M
EVT icon
480
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.17B
$1.32M 0.03%
68,441
-40,783
-37% -$767K
FXD icon
481
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$274M
$1.3M 0.03%
+34,884
New +$1.17M
P
482
Everpure Inc
P
$32.6B
$1.3M 0.03%
75,150
-1,000
-1% -$15K
CAE icon
483
CAE Inc. Common Shares
CAE
$8.64B
$1.3M 0.03%
80,400
-16,410
-17% -$254K
CDW icon
484
CDW
CDW
$17.1B
$1.29M 0.03%
11,147
-319
-3% -$34.6K
MCI
485
Barings Corporate Investors
MCI
$341M
$1.28M 0.03%
95,657
+2,200
+2% +$29.2K
CARR icon
486
Carrier Global
CARR
$52.3B
$1.28M 0.03%
+57,823
New +$1.07M
FSLY icon
487
Fastly Inc
FSLY
$4.42B
$1.27M 0.03%
14,974
-52,848
-78% -$2.08M
VIGI icon
488
Vanguard International Dividend Appreciation ETF
VIGI
$9.28B
$1.27M 0.03%
18,965
+13,600
+253% +$861K
FPX icon
489
First Trust US Equity Opportunities ETF
FPX
$1.48B
$1.27M 0.03%
15,166
-158
-1% -$11.9K
RQI icon
490
Cohen & Steers Quality Income Realty Fund
RQI
$1.68B
$1.27M 0.03%
116,346
+4,876
+4% +$49.2K
CPZ
491
Calamos Long/Short Equity & Dynamic Income Trust
CPZ
$268M
$1.27M 0.03%
81,758
+42,372
+108% +$643K
HQH
492
abrdn Healthcare Investors
HQH
$1.33B
$1.26M 0.03%
59,245
+12,933
+28% +$264K
XEL icon
493
Xcel Energy
XEL
$48B
$1.26M 0.03%
20,172
-4,248
-17% -$268K
NXG
494
NXG NextGen Infrastructure Income Fund
NXG
$344M
$1.25M 0.03%
40,948
+6,359
+18% +$187K
FXH icon
495
First Trust Health Care AlphaDEX Fund
FXH
$1.12B
$1.25M 0.03%
13,880
-810
-6% -$69.5K
TEVA icon
496
Teva Pharmaceuticals
TEVA
$42.1B
$1.25M 0.03%
101,559
-56,978
-36% -$644K
AZTA icon
497
Azenta
AZTA
$1.54B
$1.25M 0.03%
28,230
+575
+2% +$22K
ARE icon
498
Alexandria Real Estate Equities
ARE
$8.32B
$1.25M 0.03%
7,688
-167
-2% -$25.5K
RDS.A
499
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.25M 0.03%
38,109
-21,490
-36% -$737K
WCN
500
Waste Connections
WCN
$41.8B
$1.23M 0.03%
13,114
+2,568
+24% +$229K

Similar funds

Oppenheimer & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Oppenheimer & Co held 1,345 positions worth $3.87B, up 17% from $3.29B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oppenheimer & Co's Q2 2020 filing shows 153 new, 459 increased, 571 reduced and 93 closed positions. Its largest new stake was Chegg: 80,419 shares worth $5.41M. The largest sale was Invesco QQQ Trust, an estimated $21.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q2 2020 buy was Chegg: 80,419 shares worth $5.41M.
  • Oppenheimer & Co added most to ProShares Short S&P500 in Q2 2020, an estimated $10.6M increase.
  • Oppenheimer & Co's biggest Q2 2020 reduction was Invesco QQQ Trust, cutting an estimated $21.5M.
  • Oppenheimer & Co fully exited State Street SPDR Portfolio S&P 500 High Dividend ETF in Q2 2020, selling an estimated $6.47M.
  • Oppenheimer & Co's ten largest holdings make up 19% of its $3.87B portfolio in Q2 2020.
  • Oppenheimer & Co opened 153 new positions and closed 93 in Q2 2020.
  • Oppenheimer & Co's portfolio value rose 17% quarter-over-quarter to $3.87B.

Based on Oppenheimer & Co's 13F filing for Q2 2020, filed 11 Aug 2020.